MCID: PRC012
MIFTS: 50

Pericardial Effusion

Categories: Cardiovascular diseases

Aliases & Classifications for Pericardial Effusion

MalaCards integrated aliases for Pericardial Effusion:

Name: Pericardial Effusion 12 29 52 14 69

Classifications:



External Ids:

Disease Ontology 12 DOID:118
MeSH 42 D010490
NCIt 47 C3319
SNOMED-CT 64 373945007 70370001
ICD10 33 I31.3
UMLS 69 C0031039

Summaries for Pericardial Effusion

Disease Ontology : 12 A pericardium disease that is characterized by an abnormal accumulation of fluid in the pericardial cavity.

MalaCards based summary : Pericardial Effusion is related to chronic myelomonocytic leukemia and pulmonary embolism. An important gene associated with Pericardial Effusion is ADA (Adenosine Deaminase), and among its related pathways/superpathways are Embryonic and Induced Pluripotent Stem Cell Differentiation Pathways and Lineage-specific Markers and MicroRNAs in cardiomyocyte hypertrophy. The drugs Colchicine and Diclofenac have been mentioned in the context of this disorder. Affiliated tissues include heart, lung and myeloid, and related phenotypes are cardiovascular system and homeostasis/metabolism

Wikipedia : 72 Pericardial effusion (\"fluid around the heart\") is an abnormal accumulation of fluid in the... more...

Related Diseases for Pericardial Effusion

Diseases related to Pericardial Effusion via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 292)
id Related Disease Score Top Affiliating Genes
1 chronic myelomonocytic leukemia 30.0 CRP IL6 REN
2 pulmonary embolism 30.0 ADA CRP IL6
3 pericarditis 29.6 ACVRL1 CRP FGF2 REN VEGFA
4 myocardial infarction 27.5 CHKB CRP HIF1A IL6 NPPA NPPB
5 hemopericardium 11.9
6 cardiac tamponade 11.4
7 lymphedema, hereditary, iii 11.1
8 hypertrichotic osteochondrodysplasia 11.1
9 camptodactyly-arthropathy-coxa vara-pericarditis syndrome 11.0
10 hypertrichotic osteochondrodysplasia cantu type 11.0
11 pericardial tuberculosis 11.0
12 dressler's syndrome 11.0
13 virilizing ovarian tumor 10.7 IL6 PIK3C2A
14 chronic granulomatous disease 10.7 NPPB REN
15 cutaneous leishmaniasis 10.7 IL6 VEGFA
16 collagenopathy type 2 alpha 1 10.7 CRP IL6
17 crohn disease-associated growth failure 10.7 IL6 VEGFA
18 ciliary discoordination, due to random ciliary orientation 10.6 CRP NPPB
19 urethral gland abscess 10.6 ADA CRP
20 crystal arthropathies 10.6 CRP IL6
21 monosomy 13q34 10.6 IL6 REN
22 lateral myocardial infarction 10.6 NPPB PIK3C2A
23 shoulder impingement syndrome 10.6 CRP IL6
24 brachydactyly-distal symphalangism syndrome 10.6 CRP IL6
25 idiopathic peripheral autonomic neuropathy 10.6 ADA NPPB
26 atrial septal defect 7, with or without av conduction defects 10.6 NPPA REN
27 hypodontia of incisors and premolars 10.6 NPPA REN
28 repetitive stress injuries 10.6 NPPA REN
29 myopathy, distal, tateyama type 10.5 CHKB PIK3C2A
30 velocardiofacial syndrome 10.5 CHKB PIK3C2A
31 clitoris cancer 10.5 NPPA REN
32 iridogoniodysgenesis and skeletal anomalies 10.5 HIF1A VEGFA
33 tumefactive multiple sclerosis 10.5 ADA NPPA VEGFA
34 erythema elevatum diutinum 10.5 CRP IL6 VEGFA
35 ventricular tachycardia, catecholaminergic polymorphic, 1 10.5 ACADVL NPPB PIK3C2A
36 ischemic heart disease 10.5 CRP IL6 VEGFA
37 pneumoconiosis 10.5 ADA CRP IL6
38 epstein-barr virus hepatitis 10.5 CRP IL6 PIK3C2A
39 x-linked dominant intellectual disability-epilepsy syndrome 10.5 CRP IL6
40 opportunistic bacterial infectious disease 10.4 ADA CRP IL6
41 parasitic helminthiasis infectious disease 10.4 CRP IL6 PIK3C2A
42 scabies 10.4 ADA CRP IL6
43 porokeratosis 3, multiple types 10.4 CRP TNFRSF1A
44 angina pectoris 10.4 CRP IL6 VEGFA
45 atrophy of prostate 10.4 CRP IL6 PIK3C2A
46 dementia pugilistica 10.4 IL6 NPPB PIK3C2A
47 mixed mineral dust pneumoconiosis 10.4 CRP IL6 PIK3C2A
48 adams-oliver syndrome 5 10.4 CRP NPPB REN
49 scn8a encephalopathy 10.4 FGF2 PIK3C2A
50 pyriform sinus cancer 10.4 NPPA NPPB

Graphical network of the top 20 diseases related to Pericardial Effusion:



Diseases related to Pericardial Effusion

Symptoms & Phenotypes for Pericardial Effusion

MGI Mouse Phenotypes related to Pericardial Effusion:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.21 ACADVL ACVRL1 ADA CRP FGF2 HIF1A
2 homeostasis/metabolism MP:0005376 10.18 ACADVL ACVRL1 ADA CHKB CRP FGF2
3 behavior/neurological MP:0005386 10.16 ACADVL ACVRL1 CHKB FGF2 HIF1A IL6
4 hematopoietic system MP:0005397 10.1 ACVRL1 ADA FGF2 HIF1A IL6 NPPA
5 muscle MP:0005369 10 ADA CHKB FGF2 HIF1A IL6 NPPA
6 liver/biliary system MP:0005370 9.87 ACADVL ACVRL1 ADA HIF1A IL6 TNFRSF1A
7 neoplasm MP:0002006 9.63 IL6 TNFRSF1A VEGFA ACADVL FGF2 HIF1A
8 nervous system MP:0003631 9.61 ACVRL1 CHKB FGF2 HIF1A IL6 PIK3C2A
9 renal/urinary system MP:0005367 9.28 VEGFA ACVRL1 ADA HIF1A IL6 NPPA

Drugs & Therapeutics for Pericardial Effusion

Drugs for Pericardial Effusion (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 131)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Colchicine Approved Phase 4,Phase 3 64-86-8 6167 2833
2
Diclofenac Approved, Vet_approved Phase 4 15307-86-5 3033
3
Everolimus Approved Phase 4 159351-69-6 6442177
4
Miconazole Approved, Investigational, Vet_approved Phase 4 22916-47-8 4189
5
Mycophenolate mofetil Approved, Investigational Phase 4 128794-94-5 5281078
6
Mycophenolic acid Approved Phase 4 24280-93-1 446541
7
Sirolimus Approved, Investigational Phase 4 53123-88-9 5284616 6436030 46835353
8 Antirheumatic Agents Phase 4,Phase 3,Phase 2
9 Antimitotic Agents Phase 4,Phase 3,Phase 2,Phase 1
10 Anti-Infective Agents Phase 4,Phase 2,Phase 1
11 Immunosuppressive Agents Phase 4,Phase 2,Phase 3,Phase 1
12 Analgesics Phase 4
13 Analgesics, Non-Narcotic Phase 4
14 Anti-Inflammatory Agents Phase 4,Phase 3
15 Anti-Inflammatory Agents, Non-Steroidal Phase 4
16 Cyclooxygenase Inhibitors Phase 4
17 Peripheral Nervous System Agents Phase 4,Phase 3
18 Anti-Bacterial Agents Phase 4,Phase 3,Phase 1,Phase 2
19 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 1,Phase 2
20 Antifungal Agents Phase 4
21 Cyclosporins Phase 4
22
Bleomycin Approved Phase 3 11056-06-7 5360373
23
Methylprednisolone Approved, Vet_approved Phase 3 83-43-2 6741
24
Prednisolone Approved, Vet_approved Phase 3 50-24-8 5755
25
Cyclophosphamide Approved, Investigational Phase 2, Phase 3 50-18-0, 6055-19-2 2907
26
Mesna Approved Phase 2, Phase 3 3375-50-6 598
27
Carboplatin Approved Phase 3,Phase 2,Phase 1 41575-94-4 10339178 498142 38904
28
Paclitaxel Approved, Vet_approved Phase 3,Phase 2,Phase 1 33069-62-4 36314
29
Dasatinib Approved, Investigational Phase 3,Phase 1,Phase 2 302962-49-8 3062316
30
Prednisone Approved, Vet_approved Phase 3 53-03-2 5865
31
Docetaxel Approved May 1996, Investigational Phase 3,Phase 2 114977-28-5 148124 9877265
32 Antiemetics Phase 3
33 Antineoplastic Agents, Hormonal Phase 3
34 Autonomic Agents Phase 3
35 Gastrointestinal Agents Phase 3
36 glucocorticoids Phase 3
37 Hormone Antagonists Phase 3
38 Hormones Phase 3
39 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3
40 Methylprednisolone acetate Phase 3
41 Methylprednisolone Hemisuccinate Phase 3
42 Neuroprotective Agents Phase 3
43 Prednisolone acetate Phase 3
44 Prednisolone hemisuccinate Phase 3
45 Prednisolone phosphate Phase 3
46 Protective Agents Phase 3
47 Vaccines Phase 3
48 Alkylating Agents Phase 2, Phase 3
49 Antilymphocyte Serum Phase 2, Phase 3
50 Albumin-Bound Paclitaxel Phase 3,Phase 2,Phase 1

Interventional clinical trials:

(show top 50) (show all 69)

id Name Status NCT ID Phase Drugs
1 Non Steroidal Anti Inflammatory Treatment for Post Operative Pericardial Effusion Completed NCT00247052 Phase 4 diclofenac;diclofenac;matching placebo
2 Cochicine Treatment for Post- Operative Pericardial Effusion Completed NCT01266694 Phase 4 Colchicines;Placebo
3 Everolimus in de Novo Heart Transplant Recipients Completed NCT01017029 Phase 4 Everolimus;Mycophenolate mofetil + Everolimus
4 Impact of Colchicine Therapy on Arrhythmia Recurrence After Acute Pericardial Effusion Recruiting NCT02260206 Phase 4 Colchicine
5 The Effect of Chest Tubes Using Active Clearance Technology® on the Incidence of Postoperative Atrial Fibrillation Recruiting NCT02808897 Phase 4
6 Safety, Tolerability, Pharmacokinetics and Efficacy of Two Different Rates of Subcutanous Remodulin® Dose Titration in Pulmonary Arterial Hypertension Withdrawn NCT02893995 Phase 4 Slow Dose Titration Group of Subcutaneous Treprostinil;Rapid Dose Titration Group of Subcutaneous Treprostinil
7 COlchicine for Prevention of the Post-pericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 Trial) Unknown status NCT01552187 Phase 3 Colchicine;Placebo
8 Trial of Drainage With or Without Bleomycin Instillation for Malignant Pericardial Effusion Completed NCT00132613 Phase 3 Pericardial instillation of bleomycin after drainage
9 A Trial of Adjunctive Prednisolone and Mycobacterium w Immunotherapy in Tuberculous Pericarditis Completed NCT00810849 Phase 3 Prednisolone
10 Scleroderma: Cyclophosphamide or Transplantation (SCOT) Completed NCT00114530 Phase 2, Phase 3 cyclophosphamide
11 Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer Completed NCT00347412 Phase 3 Paclitaxel and Carboplatin;NOV-002 Injection in combination with Carboplatin vs. Paclitaxel and Carboplatin
12 Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate Cancer Completed NCT00744497 Phase 3 Placebo;Dasatinib;Docetaxel;Prednisone
13 IMPI 2 - A Trial of Intrapericardial Alteplase in Large Pericardial Effusion Recruiting NCT02673879 Phase 3
14 Safety And Efficacy Of Sildenafil In Children With Pulmonary Arterial Hypertension Active, not recruiting NCT01642407 Phase 3 Sildenafil
15 NGR-hTNF in Combination With Standard Chemotherapy to Treat Patients With Advanced Non-small Cell Lung Cancer Unknown status NCT00994097 Phase 2 NGR-hTNF;Cisplatin;Gemcitabine;Pemetrexed
16 ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment Unknown status NCT00005645 Phase 2 ILX-295501
17 Combined CABG and Stem-Cell Transplantation for Heart Failure Unknown status NCT00418418 Phase 2
18 Phase I/II Safety Study of IPI-504 in Relapsed/Refractory Stage IIIb, or Stage IV Non-small Cell Lung Cancer (NSCLC) Completed NCT00431015 Phase 1, Phase 2 IPI-504
19 Dasatinib (Sprycel™) in Patients With Newly Diagnosed Core Binding Factor (CBF) Acute Myeloid Leukemia (AML) Completed NCT00850382 Phase 1, Phase 2 Dasatinib;daunorubicin;Cytarabine
20 A Study of Bevacizumab Plus Carboplatin and Paclitaxel in Subjects With Advanced, Previously Untreated, Squamous Non-Small Cell Lung Cancer (BRIDGE) Completed NCT00318136 Phase 2 Bevacizumab;Carboplatin;Paclitaxel
21 Phase II Study of Cetuximab in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer Completed NCT00251498 Phase 2 Cetuximab
22 Triplet Combination First Line Treatment in Non Small Cell Lung Cancer (NSCLC) Completed NCT00942825 Phase 2 CBP501 + Cisplatin + Pemetrexed;Cisplatin + Pemetrexed
23 Safety and Efficacy Evaluation of Two Year Imatinib Treatment in Adjuvant Gastrointestinal Stromal Tumor (GIST) Completed NCT01172548 Phase 2 imatinib mesylate
24 QUILT-2.013: A Trial of AMG 479 or AMG 102 in Combination With Platinum-based Chemotherapy as First-Line Treatment for Extensive Stage Small Cell Lung Cancer Completed NCT00791154 Phase 1, Phase 2 AMG 479;Etoposide;Placebo;AMG 102;Carboplatin;Cisplatin
25 Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer Completed NCT00508144 Phase 2 Alimta
26 The Effects Of Fx-1006A On Transthyretin Stabilization And Clinical Outcome Measures In Patients With V122I Or Wild-Type TTR Amyloid Cardiomyopathy Completed NCT00694161 Phase 2 Fx-1006A
27 Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer Active, not recruiting NCT00126581 Phase 2 Carboplatin;Erlotinib Hydrochloride;Paclitaxel
28 Intrapleural Bevacizumab Injection for Malignant Effusion in Lung Cancer Enrolling by invitation NCT02054052 Phase 2 Bevacizumab
29 Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu Completed NCT00004074 Phase 1
30 Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer Completed NCT00005842 Phase 1 tipifarnib
31 Pericardiocentesis With Magnetic Resonance Imaging Terminated NCT01479569 Phase 1
32 Drainage or Pericardiocentesis (DROP) Alone for Recurrent Non-malignant Pericardial Effusions Requiring Intervention Unknown status NCT01665495
33 Prevention of Retained-Blood Outcomes With Active Clearance Technology Unknown status NCT02145858
34 Contact Force Sensing and Pulmonary Vein Isolation Unknown status NCT01630031
35 Pleural and Pericardial Effusion Following Open Heart Surgery Completed NCT02045641
36 Evaluation of Different Strategies of Pericardial Drainage After Aortic Valvular Surgery Completed NCT00684125
37 Screening of Patients Admitted to a Local Hospital With Pocket-sized Ultrasound Completed NCT01081210
38 BRIPPED Scan for Evaluation of Emergency Department (ED) Patients With Shortness of Breath Completed NCT01662843
39 Influence of Routinely Adding Ultrasound Screening in Medical Department Completed NCT01331187
40 Single-operator Ultrasound-guided IV Placement by Emergency Nurses Completed NCT01439113
41 "EASE" Epicardial Access With the EpiAccess System Completed NCT02209064
42 A Study of Strategies for Electrical Isolation of Pulmonic Veins for Curative Treatment of Atrial Fibrillation Completed NCT00434694
43 Validation of Epworth Richmond's Echocardiography Education Focused Year Completed NCT02961439
44 Establishment of Patient Derived Cancer Cell Models to Interrogate Novel Molecular Targets in Metastatic Cancer Recruiting NCT02646228
45 Improvement of the Etiological Diagnosis of the Pericarditis Recruiting NCT02828085
46 Canadian Left Atrial Appendage Closure Study Recruiting NCT03133806
47 Active Clearance Technology (ACT) II German Multicenter Trial Recruiting NCT02479737
48 Impact of Immediate Point-of-Care Ultrasound on Patients With Cardiopulmonary Symptoms in the Emergency Department Recruiting NCT02861508
49 Serotype Distribution of Streptococcus Pneumoniae That Causes Invasive Diseases at Children and Adults in Turkey Recruiting NCT01810861
50 Influence of EPICardial Adipose Tissue in HEART Diseases: EPICHEART Study Recruiting NCT03280433

Search NIH Clinical Center for Pericardial Effusion

Genetic Tests for Pericardial Effusion

Genetic tests related to Pericardial Effusion:

id Genetic test Affiliating Genes
1 Pericardial Effusion 29

Anatomical Context for Pericardial Effusion

MalaCards organs/tissues related to Pericardial Effusion:

39
Heart, Lung, Myeloid, Liver, Prostate, Kidney, Endothelial

Publications for Pericardial Effusion

Articles related to Pericardial Effusion:

(show top 50) (show all 724)
id Title Authors Year
1
Chest Pain Due to Pericardial Effusion as Initial Presenting Feature of Rheumatoid Arthritis: Case Report and Review of the Literature. ( 28868101 )
2017
2
Chondrosarcoma: Extrinsic Compression of the Right Ventricle and Pericardial Effusion. ( 28709860 )
2017
3
Uremic pericarditis, pericardial effusion, and constrictive pericarditis in end-stage renal disease: Insights and pathophysiology. ( 28873222 )
2017
4
Incidence and Predictors of Pericardial Effusion After Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer. ( 28816165 )
2017
5
Case of generalized pustular psoriasis presenting with both pleural effusion and pericardial effusion collection. ( 28636215 )
2017
6
Massive Pericardial Effusion and Tamponade Can Be a First Sign of Familial Mediterranean Fever. ( 28763406 )
2017
7
Pericardial effusion is correlated with clinical outcome after pulmonary artery denervation for pulmonary arterial hypertension. ( 28903327 )
2017
8
Infantile Systemic Hyalinosis Complicated with Right Atrial Thrombus and Pericardial Effusion in an Infant. ( 25458638 )
2017
9
Incidence and Outcome of Pericardial Effusion in Pediatric Patients After Hematopoietic Stem Cell Transplant: A Single-institution Experience. ( 28945662 )
2017
10
Novel echocardiographic prognostic markers for cardiac tamponade in patients with large malignant pericardial effusions: A paradigm shift from flow to tissue imaging. ( 28685870 )
2017
11
Ethanol injection into the Marshall vein provoking a pericardial effusion resulting in a fatal complication in a patient with persistent atrial fibrillation. ( 28878915 )
2017
12
Corrigendum to "Prenatal Diagnosis of Cardiac Diverticulum with Pericardial Effusion in the First Trimester of Pregnancy with Resolution after Early Pericardiocentesis". ( 28811945 )
2017
13
Automatic detection of hemorrhagic pericardial effusion on PMCT using deep learning - a feasibility study. ( 28819715 )
2017
14
The Echocardiographic Characteristics and Prognostic Significance of Pericardial Effusions in Eisenmenger Syndrome. ( 28882496 )
2017
15
Intracerebral Bleeding and Massive Pericardial Effusion as Presenting Symptoms of Myxedema Crisis. ( 28255471 )
2017
16
Pericardial Effusion: A Rare Side Effect of TNF-Alpha Blocking Agent. ( 28742729 )
2017
17
Prevalence of vomiting in dogs with pericardial effusion. ( 28079972 )
2017
18
Use of Yunnan Baiyao and epsilon aminocaproic acid in dogs with right atrial masses and pericardial effusion. ( 27669112 )
2017
19
Diagnosis of systemic inflammatory diseases among patients admitted for acute pericarditis with pericardial effusion. ( 28937580 )
2017
20
Acute rhabdomyolysis and delayed pericardial effusion in an Italian patient with Ebola virus disease: a case report. ( 28854896 )
2017
21
Intra-Pericardial Use of Recombinant Factor VIIa in a Patient With Acute Hemorrhagic Pericardial Effusion Following Transcutaneous Aortic Valve Replacement-A Case Report. ( 28934519 )
2017
22
Relapsed Multiple Myeloma Presenting as Intracranial Plasmacytoma and Malignant Pericardial Effusion following Recent Allogeneic Stem Cell Transplantation. ( 28868016 )
2017
23
Comparison of distinctive clinical and cardiac magnetic resonance features between ST elevation myocardial infarction patients with incomplete myocardial rupture and those with moderate to severe pericardial effusion. ( 28730842 )
2017
24
Long-Term Outcomes after Video-Assisted Thoracoscopic Pericardiectomy for Pericardial Effusion. ( 28794388 )
2017
25
Focal intramural pericardial effusion and cardiac tamponade associated with necrotic adipose tissue in a dog. ( 28671499 )
2017
26
Case report: A case of pericardial effusion presenting to primary care. ( 28889141 )
2017
27
Huge pericardial effusion with subcutaneous emphysema, pneumomediastinum and pneumopericardium in anorexia nervosa. ( 28799456 )
2017
28
Upper gastrointestinal tract symptoms are predictors of postoperative large pericardial effusion in cardiac surgery. ( 28839323 )
2017
29
Pericardial effusion is correlated with clinical outcome after pulmonary artery denervation for pulmonary arterial hypertension. ( 28009987 )
2016
30
Incorrect catheter placement for drainage of malignant pericardial effusion. ( 27733272 )
2016
31
Massive right pleural effusion leading to cardiac tamponade in absence of pericardial effusion: a rare presentation. ( 26843420 )
2016
32
Left ventricular diastolic dysfunction and increased left ventricular mass index related to pulmonary hypertension in patients with systemic autoimmune disease without pericardial effusion. ( 27390939 )
2016
33
Chronic active Epstein-Barr virus infection with marked pericardial effusion successfully treated with allogeneic peripheral blood stem cell transplantation. ( 27263789 )
2016
34
The role of FDG uptake intensity in pericardial effusion. ( 27444502 )
2016
35
Unexpected detection of pericardial effusion on myocardial perfusion scintigraphy. ( 27833327 )
2016
36
A "Vanishing", Tuberculous, Pericardial Effusion. ( 27826351 )
2016
37
B-type natriuretic peptide levels in patients with pericardial effusion undergoing pericardiocentesis. ( 27057950 )
2016
38
A case of Meigs' syndrome with preceding pericardial effusion in advance of pleural effusion. ( 27160723 )
2016
39
Dynamic Variables Fail to Predict Fluid Responsiveness in an Animal Model With Pericardial Effusion. ( 27499343 )
2016
40
Pericardial effusion and cardiac tamponade after ventriculoperitoneal shunt placement: a case report. ( 27502774 )
2016
41
Sanguineous Pericardial Effusion and Cardiac Tamponade in the Setting of Graves' Disease: Report of a Case and Review of Previously Reported Cases. ( 27446216 )
2016
42
Angiosarcoma of the Right Atrium with Extension to SVC and IVC Presenting with Complete Heart Block and Significant Pericardial Effusion. ( 27110407 )
2016
43
Morgagni hernia presenting with massive pericardial effusion and ascites: prenatal management by thoraco-amniotic shunting and fetal endoscopic tracheal occlusion (FETO) and review of the literature. ( 27126202 )
2016
44
Giant pericardial effusion: drain it all? ( 27125952 )
2016
45
Docetaxel-induced pericardial effusion. ( 27105899 )
2016
46
Hemorrhagic Pericardial Effusion with Tamponade: A Rare Adverse Effect of Infliximab-Case Report and Literature Review. ( 27822400 )
2016
47
Prenatal diagnosis of 22q11.2 deletion syndrome associated with right aortic arch, left ductus arteriosus, cardiomegaly, and pericardial effusion. ( 26927262 )
2016
48
Pericardial effusion requiring surgical intervention after stem cell transplantation: a case series. ( 27991890 )
2016
49
Novel, Long-axis In-plane Ultrasound-Guided Pericardiocentesis for Postoperative Pericardial Effusion Drainage. ( 27421844 )
2016
50
A 30-year-old female BehAset's disease patient with recurrent pleural and pericardial effusion and elevated adenosine deaminase levels: case report. ( 27499994 )
2016

Variations for Pericardial Effusion

Expression for Pericardial Effusion

Search GEO for disease gene expression data for Pericardial Effusion.

Pathways for Pericardial Effusion

GO Terms for Pericardial Effusion

Cellular components related to Pericardial Effusion according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.61 CRP FGF2 IL6 NPPA NPPB PVR
2 cell surface GO:0009986 9.55 ACVRL1 ADA PVR TNFRSF1A VEGFA
3 extracellular space GO:0005615 9.32 ADA CRP FGF2 IL6 NPPA NPPB

Biological processes related to Pericardial Effusion according to GeneCards Suite gene sharing:

(show all 27)
id Name GO ID Score Top Affiliating Genes
1 positive regulation of gene expression GO:0010628 9.92 CRP HIF1A IL6 VEGFA
2 negative regulation of cell growth GO:0030308 9.77 ACVRL1 NPPA NPPB
3 angiogenesis GO:0001525 9.76 ACVRL1 FGF2 HIF1A VEGFA
4 response to drug GO:0042493 9.75 ADA IL6 REN
5 positive regulation of neuroblast proliferation GO:0002052 9.63 HIF1A VEGFA
6 positive regulation of heart rate GO:0010460 9.63 ADA NPPA
7 muscle cell cellular homeostasis GO:0046716 9.62 HIF1A IL6
8 regulation of blood vessel size GO:0050880 9.61 NPPA NPPB
9 negative regulation of blood vessel endothelial cell migration GO:0043537 9.61 ACVRL1 FGF2
10 positive regulation of tyrosine phosphorylation of STAT protein GO:0042531 9.61 IL6 TNFRSF1A VEGFA
11 positive regulation of chemokine production GO:0032722 9.59 HIF1A IL6
12 positive regulation of vascular endothelial growth factor receptor signaling pathway GO:0030949 9.57 HIF1A VEGFA
13 cell migration involved in sprouting angiogenesis GO:0002042 9.56 FGF2 VEGFA
14 positive regulation of angiogenesis GO:0045766 9.56 ACVRL1 FGF2 HIF1A VEGFA
15 receptor guanylyl cyclase signaling pathway GO:0007168 9.54 NPPA NPPB
16 response to lipopolysaccharide GO:0032496 9.54 IL6 REN TNFRSF1A
17 cellular response to mechanical stimulus GO:0071260 9.52 NPPA TNFRSF1A
18 negative regulation of lipid storage GO:0010888 9.51 CRP IL6
19 retina vasculature development in camera-type eye GO:0061298 9.48 ACVRL1 HIF1A
20 regulation of blood pressure GO:0008217 9.46 ACVRL1 NPPA NPPB REN
21 negative regulation of thymocyte apoptotic process GO:0070244 9.4 ADA HIF1A
22 positive regulation of transcription from RNA polymerase II promoter in response to hypoxia GO:0061419 9.32 HIF1A VEGFA
23 cell growth involved in cardiac muscle cell development GO:0061049 9.28 NPPA
24 positive regulation of endothelial cell proliferation GO:0001938 9.26 ACVRL1 FGF2 HIF1A VEGFA
25 negative regulation of systemic arterial blood pressure GO:0003085 9.19 NPPA
26 response to hypoxia GO:0001666 9.02 ACVRL1 ADA HIF1A NPPA VEGFA
27 positive regulation of transcription from RNA polymerase II promoter GO:0045944 10.02 ACVRL1 FGF2 HIF1A IL6 TNFRSF1A VEGFA

Molecular functions related to Pericardial Effusion according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 receptor binding GO:0005102 9.02 IL6 NPPA NPPB PVR REN
2 peptide hormone receptor binding GO:0051428 8.65 NPPA

Sources for Pericardial Effusion

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....